title: Cardiovascular risk factors in Assyrians/Syrians and native Swedes with type 2 diabetes: a population-based epidemiological study.
abstract: BACKGROUND
  A large number of people throughout the world have diabetes and the prevalence is increasing. Persons with diabetes have a twice higher risk of cardiovascular disease than those without diabetes. There is a lack of studies focusing on cardiovascular risk factors in Assyrians/Syrians with type 2 diabetes. The aim of this study is to estimate the prevalence of some cardiovascular risk factors among Assyrians/Syrians and native Swedes with type 2 diabetes and to study whether the association between ethnicity and cardio-vascular risk factors remains after adjustment for age, gender, employment status and housing tenure.
  
  
  METHODS
  In the Swedish town of Södertälje 173 Assyrians/Syrians and 181 ethnic Swedes with type 2 diabetes participated in a study evaluating cardiovascular risk factors such as increased haemoglobin A1c (HbA1c), high blood lipids (total serum cholesterol and triglycerides), hypertension and high urinary albumin. The associations between the outcome variables and sociodemographic characteristics were estimated using unconditional logistic regression.
  
  
  RESULTS
  The prevalence of increased triglycerides in Swedish-born subjects and Assyrian-Syrians was 61.5% and 39.7% respectively. Swedes had a prevalence of hypertension 76.8% compared to 57.8% in Assyrians/Syrians. In the final logistic models adjusted for gender, age, housing and employment the odds ratio (OR) for Swedish-born subjects for increased triglycerides was 2.80 (95% CI1.61-4.87) and for hypertension 2.32 (95% CI 1.35-4.00) compared to Assyrians-Syrians.
  
  
  CONCLUSIONS
  Ethnic Swedes had higher prevalence of increased triglycerides and hypertension than Assyrians/Syrians. Total cholesterol, HbA1c and urinary albumin did not differ between the two ethnic groups.
authors.affiliation: Center for Primary Health Care Research, Region Skåne, Lund University, Sweden, UMAS, 205 02 Malmö, Sweden. marina.taloyan@sll.se
authors.forename: Marina
authors.initials: M
authors.lastname: Taloyan
authors.forename: Alexandre
authors.initials: A
authors.lastname: Wajngot
authors.forename: Sven-Erik
authors.initials: SE
authors.lastname: Johansson
authors.forename: Jonas
authors.initials: J
authors.lastname: Tovi
authors.forename: Jan
authors.initials: J
authors.lastname: Sundquist
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000208:ethnology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology / Q000208:ethnology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000453:epidemiology / Q000208:ethnology; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology / Q000208:ethnology; D013593:Syria / Q000208:ethnology; D014280:Triglycerides / Q000097:blood; D044465:White People / Q000208:ethnology*
chemical_list: D014280:Triglycerides